CDC Immunizations Information Systems (IIS) Vaccine Code Set Release Notes

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]



      You are subscribed to one or more CDC code sets email subscription services. This message serves to inform you that information has recently been updated and is now available.

      Web Services Publication Date: September 13, 2019
      The individual filenames included in this distribution contain the publication date (20190913)

      Release Notes: This release does not include updates for Vaccine Information Statement (VIS) codes and maps. A separate set of release notes and files are prepared for VIS code updates and will be distributed in a separate release cycle. 

      General Note regarding this release: Codes with “Last Update” dates after September 2, 2019 reflect changes and additions in this release and include the following code set updates:

      1) CVX/ Vaccine Group Code Updates:
      • New Vaccine Group Added: DENGUE 
      • CVX Code 56 “dengue fever vaccine” status changed from “Never Active” to “Active” and mapped to the new Vaccine Group “DENGUE”.

      2) CDC Product Tradename/CVX/MVX Table Updates:
      • Product Added: A new product, “DENGVAXIA”, has been added to represent this new tetravalent vaccine. It is mapped to MVX – “PMC” (Sanofi Pasteur), and CVX 56 “dengue fever vaccine”.

      3) NDC Code Updates:
      • The following NDCs have been added:


      Sale Proprietary Name

      Sale Labeler

      Sale NDC11

      Use NDC11

      FluMist Quadrivalent

      MedImmune, LLC

      66019-0306-10

      66019-0306-01

      DENGVAXIA

      Sanofi Pasteur

      49281-0605-01

      49281-0606-58*


      *It should be noted that DENGVAXIA is provided in a kit. The Unit of Use listed above contains the antigen, a second NDC, 49281-0549-58 is included in the kit but is a saline diluent that is not included in the CDC code set NDCs listed.

      • The following NDCs have been retired:

      Sale Proprietary Name

      Sale Labeler

      Sale NDC11

      Use NDC11

      ENGERIX-B

      GlaxoSmithKline Biologicals SA

      58160-0820-11

      58160-0820-01

      FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE)

      Seqirus, Inc.

      70461-0318-03

      70461-0318-04


      Note: The two NDCs for FLUCELVAX QUADRIVALENT (above) were incorrectly listed in the previous release notes as new vaccines. They should have been listed in the table of retired NDCs.


      Centers for Disease Control and Prevention


      [Index of Archives]     [NIH News]     [FDA News]     [USDA News]     [Yosemite News]     [Steve's Art]     [SB Lupus]     [STB]
        Powered by Linux